Seattle, WA, United States of America

Carol-Ann Cole

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Genetic Systems Corporation, Bio-Rad Laboratories, Inc.. Active years: 1993-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carol-Ann Cole. Retrieved from https://idiyas.com/inventor/carol-ann-cole

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1993-2006

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carol-Ann Cole

Introduction

Carol-Ann Cole is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of immunology, particularly in the development of synthetic antigens and peptides for the detection of antibodies related to HIV and other retroviruses. With a total of 4 patents, her work has had a substantial impact on medical diagnostics.

Latest Patents

One of her latest patents is focused on a synthetic antigen for the detection of antibodies immunoreactive with the HIV virus. This patent describes novel polypeptides that have sequences similar to immunologically significant fragments of AIDS-related viruses. These polypeptides can be utilized as reagents to determine human exposure to the virus, with particular emphasis on their application in screening blood products. Another significant patent involves cysteine thiol-protected peptides for use in immunoassays. These peptides are designed to be immunoreactive with antibodies to native proteins and contain at least two cysteine residues that help mimic an epitope of the protein. When the thiol groups are deprotected, the peptides exhibit enhanced immunoreactivity, making them particularly useful for detecting antibodies or antigens associated with retroviruses, including HIV-1, HIV-2, HTLV-I, and HTLV-II.

Career Highlights

Throughout her career, Carol-Ann Cole has worked with notable companies such as Genetic Systems Corporation and Bio-Rad Laboratories, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of immunology.

Collaborations

She has collaborated with esteemed colleagues, including Nobuo Monji and Patrick F Coleman, further enhancing her research and contributions to the scientific community.

Conclusion

Carol-Ann Cole's innovative work in the field of immunology has led to significant advancements in the detection of retroviruses. Her patents reflect her dedication to improving medical diagnostics and her contributions continue to influence the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…